直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • 生命科学
    • Transportation and Logistics
  • 经验

专利撰写与申办

About

飞翰伦敦办公室起草并向欧洲专利局(EPO)和英国知识产权局(UKIPO)提交和申办专利申请,同时也可按照专利合作条约(PCT)的规定办理专利申请。我们的欧洲专利律师与我们的美国律师合作,共同为客户的专利组合提供战略和成本效益协调服务。我们的专利申办团队能够与客户一道制定和实施各项全球专利组合战略。我们在各技术领域均积累了渊博的知识和丰富的专利申办经验,我们的专业团队与客户紧密合作,共同创建定制化战略,将客户的业务目标、内部程序、产品开发和技术融为一体。同时我们的欧洲专利律师也积累了大量的专利异议和上诉经验,这样他们在办理专利申请时既着眼于专利的执行,同时还防范各种挑战。

我们的伦敦团队汇聚了众多知名专家和经验丰富的专业人士,同时还聘请了经验丰富的青年团队成员,他们每个人都拥有丰富的技术和/或专利申办经验,他们都拥有科学和/或工程技术背景,许多成员都持有其所在技术领域的高级学位或拥有相关行业的从业经历,可以办理几乎涵盖各个行业领域的技术业务,比如石油、天然气和能源勘探、医疗器械、化学、冶金、生物技术、制药、生物制剂和生物仿制药、工业制造、机器人、消费电子产品、计算机软件和商业方法等。

我们的理念是,在起草和办理专利申请时,既要着眼于专利的执行和战略,同时还要将客户的利益和指示牢记于心。我们与客户的科学家密切合作,划定发明的界限并确定发明的范围,努力在发明挖掘/发明披露阶段为客户创造附加值。同时我们也力求有效地沟通客户的发明所取得的成就,并在专利申办过程中展现出发明的界限和优势。对于我们来说,非常重要的是聘请那些能够以高效、低成本方式让我们在高价值全球专利组合的开发中发挥主要作用的团队。

在满足PCT申请要求方面,我们的欧洲专利律师也具有详细的专业知识,包括如何起草并有效地办理满足欧洲、美国以及世界各地要求的“欧洲专利局(EPO)友好型”PCT申请等。我们的专业人士精通世界各地专利局的可专利性和专利程序标准,可以提供协调一致、始终如一且范围广泛的全球性申办战略,实现专利保护的最大化,同时最大程度地降低当地以及外国提交和申请费用。这样就可以建立更为强大的专利组合,并降低纠纷风险,例如涉及到美国同族专利的美国诉讼。而这种协调一致的方法也有助于提高专利申办的质量和效率,进而降低成本。

Everyone in this practice

经验

Comprehensive patent transactions and strategic counseling for one of the largest pharmaceutical companies in the world

Finnegan is lead and preferred IP transactions counsel for one of the largest pharmaceutical companies in the world, handling more than 50 diligence projects each year, including all IP and related transactional aspects of the matters. The transactions span the full gamut of technologies from small molecule through biologics such as antibodies, oligonucleotides, and gene therapies. Finnegan also provides extensive assistance with post-deal integration procedures and subsequent global prosecution and portfolio strategy, ensuring a seamless transition of IP assets to the company and maximum value from acquired IP.

Global prosecution and portfolio management for major pharmaceutical company

Finnegan is lead and preferred IP strategy counsel for one of the largest pharmaceutical companies in the world, handling all aspects of prosecution and portfolio management for multiple top-tier products for the client.  The work spans the gamut from drafting and prosecution through larger strategic planning, patent term extension, and pre-litigation preparation on blockbuster small molecule and biologic products in the oncology, rheumatology, immunology, neuromuscular, and cell and gene therapy spaces.

Patent protection for innovative golfing technology

Finnegan assists Acushnet Company, a leading manufacturer of golf equipment, clothing, and accessories, with the development and protection of its patent portfolio through strategic patent drafting and prosecution across a variety of technologies.

Patent services for leading electric flying taxi company Archer Aviation Inc.

Finnegan assists Archer Aviation, a leading urban air mobility company responsible for designing, developing, manufacturing, and operating electric vertical takeoff and landing aircrafts to carry passengers, with matters related to patent application drafting and global prosecution. We also provide patent counseling services.

Patent drafting and prosecution for CentralSquare’s AI technologies

Finnegan is proud to partner with CentralSquare in developing and protecting its mission-critical software and technology solutions for public sector agencies, including those serving public safety and public administration. Our team has led the drafting and prosecution of a broad portfolio of artificial intelligence (AI)-related patent applications, advancing CentralSquare’s innovations across emergency services and municipal operations. These AI technologies accelerate emergency response, streamline workflows, and strengthen data-driven decision-making for agencies and the communities they serve.

 

Working closely with CentralSquare’s inventors and in-house counsel, we ensure every application captures the technical depth of the invention while aligning with CentralSquare’s strategic goals. We prioritize clarity, enforceability, and foresight—refining claims, anticipating examiner challenges, and crafting robust Office Action responses. By anticipating industry trends in AI and preparing forward-looking applications, Finnegan positions CentralSquare’s innovations not only to be protected, but to drive lasting impact in public safety and beyond.

Patent portfolio and licensing support for AI developer Megagon Labs

Finnegan supports Megagon Labs with developing its patent portfolio directed to cutting edge artificial intelligence (AI) technologies and assists with open-source licensing matters.

More

专业见解

Conference

2026 Advanced Chemical & Biotech Patent Institute

May 11-12, 2026

San Francisco

IP Updates

PIER Pilot Program - Synopsis

April 09, 2026

Articles

Why Fashion Brands are Doubling Down on US Utility Patents

Why Fashion Brands are Doubling Down on US Utility Patents

March 10, 2026

Webinar

What’s Working at the PTAB Now: Strategies for Petitioners and Patent Owners

March 4, 2026

Webinar

Conference

American Intellectual Property Law Association – Delegation to the United Arab Emirates

February 8-12, 2026

Dubai

Articles

Different from U.S. Concepts of POSITA/PHOSITA, Proving “Common General Knowledge” Under German and the EPC Law: Why Proving Common General Knowledge Matters—and Why It’s Harder Than It Looks

December 1, 2025

More

新闻

Award/Ranking

Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked

May 28, 2026

Award/Ranking

Finnegan Wins IP Firm of the Year at the 2026 LSPN Awards

May 1, 2026

Commentary

Litigation Leaders: Finnegan’s Jennifer Roscetti on the Advantages of Being Fully Focused on IP

April 6, 2026

Award/Ranking

Finnegan Shortlisted for Eight LSPN Awards

March 2, 2026

Award/Ranking

Finnegan Nominated for Global Firm of the Year at the 2026 Managing IP EMEA Awards

February 17, 2026

Commentary

Design Patent Dissent Highlights Frustration Over Subjectivity

February 11, 2026

More

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP